Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?

Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?

Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Are Medical Stocks Lagging Assertio (ASRT) This Year?

Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Provides Update on Garda Therapeutics Tender Process

Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)

Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

Assertio Announces Agreement to be Acquired by Garda Therapeutics

Top 2 Health Care Stocks That May Implode In April

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should Know

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates

Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript

Assertio Reports Fourth Quarter and Full Year 2025 Financial Results

Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Are Medical Stocks Lagging Assertio (ASRT) This Year?

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Drops By 92.8%

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates

Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript

Assertio Reports Third Quarter 2025 Financial Results

Assertio Announces Leadership Transition

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: FINAL DEADLINE in Securities Lawsuit– Hagens Berman

CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025

New Strong Sell Stocks for September 23rd

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 3-DAY DEADLINE in Securities Lawsuit– Hagens Berman